240 related articles for article (PubMed ID: 15941947)
1. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors.
Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1394-401. PubMed ID: 15941947
[TBL] [Abstract][Full Text] [Related]
2. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.
Jernström H; Deal C; Wilkin F; Chu W; Tao Y; Majeed N; Hudson T; Narod SA; Pollak M
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):377-84. PubMed ID: 11319179
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
[TBL] [Abstract][Full Text] [Related]
4. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
Safarinejad MR; Shafiei N; Safarinejad SH
Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor polymorphisms and colorectal cancer risk.
Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1204-11. PubMed ID: 15894673
[TBL] [Abstract][Full Text] [Related]
6. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators.
Deal C; Ma J; Wilkin F; Paquette J; Rozen F; Ge B; Hudson T; Stampfer M; Pollak M
J Clin Endocrinol Metab; 2001 Mar; 86(3):1274-80. PubMed ID: 11238520
[TBL] [Abstract][Full Text] [Related]
7. IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer.
Friedrichsen DM; Hawley S; Shu J; Humphrey M; Sabacan L; Iwasaki L; Etzioni R; Ostrander EA; Stanford JL
Prostate; 2005 Sep; 65(1):44-51. PubMed ID: 15800934
[TBL] [Abstract][Full Text] [Related]
8. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
Safarinejad MR; Shafiei N; Safarinejad S
Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
[TBL] [Abstract][Full Text] [Related]
9. Influence of polymorphisms in genes encoding for insulin-like growth factor (IGF)-I, insulin, and IGF-binding protein (IGFBP)-3 on IGF-I, IGF-II, and IGFBP-3 levels in umbilical cord plasma.
Landmann E; Kollerits B; Kreuder JG; Blum WF; Kronenberg F; Rudloff S
Horm Res Paediatr; 2012; 77(6):341-50. PubMed ID: 22739332
[TBL] [Abstract][Full Text] [Related]
10. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors (United States).
Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
Cancer Causes Control; 2005 Oct; 16(8):917-27. PubMed ID: 16132801
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
[TBL] [Abstract][Full Text] [Related]
12. Common polymorphisms in the GH/IGF-1 axis contribute to growth in extremely tall subjects.
Hendriks AE; Brown MR; Boot AM; Oostra BA; de Jong FH; Drop SL; Parks JS
Growth Horm IGF Res; 2011 Dec; 21(6):318-24. PubMed ID: 21944866
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk.
Schernhammer ES; Hankinson SE; Hunter DJ; Blouin MJ; Pollak MN
Int J Cancer; 2003 Oct; 107(1):60-4. PubMed ID: 12925957
[TBL] [Abstract][Full Text] [Related]
15. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
[TBL] [Abstract][Full Text] [Related]
16. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
[TBL] [Abstract][Full Text] [Related]
17. IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans.
Hernandez W; Grenade C; Santos ER; Bonilla C; Ahaghotu C; Kittles RA
Carcinogenesis; 2007 Oct; 28(10):2154-9. PubMed ID: 17724372
[TBL] [Abstract][Full Text] [Related]
18. IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.
D'Aloisio AA; Schroeder JC; North KE; Poole C; West SL; Travlos GS; Baird DD
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):954-66. PubMed ID: 19240240
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
Diorio C; Brisson J; Bérubé S; Pollak M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
[TBL] [Abstract][Full Text] [Related]
20. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]